GAPDH and neoplasm: In the obtained FesiRNAPNPs, the GAPDH siRNA silenced the target mRNA to inhibit glycolysis, interfered with tumor energy metabolism, and enhanced Fe2+-induced ferroptosis (Scheme 1).